Elevance Health, Inc.
ELV · NYSE
- Prev Close
- $378.00
- Market Cap
- $84.92B
- Open
- —
- Trailing P/E
- —
- Day Range
- $392.35 - $370.47
- 52W Range
- $436.24 - $273.71
- Forward P/E
- —
- EPS
- —
- Volume
- 564.53K
- Dividend Yield
- —
- Beta
- —
- Avg Volume
- —
About Elevance Health, Inc.
Elevance Health is a diversified health-benefits and healthcare-services company. It makes money primarily by underwriting or administering medical coverage for government-sponsored, employer-sponsored and individual members, while its Carelon businesses provide pharmacy, behavioral-health and other care solutions. Health Benefits is the core business, with Carelon supplying a substantial but smaller services contribution; the supplied material does not provide segment percentages. Elevance reported $199.1 billion of FY2025 revenue and $5.7 billion of net income, versus $177.0 billion and $6.0 billion in FY2024, respectively. Customer and membership counts are not supplied.
Notable Price Movement
- Aug 3-7$378.000.57%
Elevance Health fell 2.00% over the reported period, from $385.73 to $378.00. The stock suffered its largest move on July 29, dropping $9.75, or 2.53%, to $375.98 on volume of 1.06 million shares. It then traded essentially sideways through July 31, closing between $375.84 and $376.40. Shares rebounded 1.84% on Monday, August 3, to $382.77, before giving back most of that gain on Tuesday, falling 1.25% to $378.00 on higher volume of 1.44 million shares. The supplied evidence contains no Elevance-specific announcement or market explanation, so the weekly move cannot be attributed to a confirmed company catalyst.
Stories & Analysis
Teladoc Health Q2 Earnings Beat Estimates on Integrated Care StrengthENSG Q2 Earnings Beat Estimates on Growing Occupancy, '26 View RaisedUnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
Humana Q2 Earnings Beat Estimates on Medical Membership Growth
